Ahead of HIMSS26, Mayo Clinic’s Ugur Sener and Taylor Galloway preview their talk on using digital tools and decentralized ...
Vaxcyte Doses First Participants in Phase 3 Study Evaluating Concomitant Administration of VAX-31 and Seasonal Influenza ...
The study will be conducted in three phases. Part A is a Phase 2, open-label, semi-sequential dose-ranging portion of the ...
High probability of technical success in pivotal Phase 3 trial based on unmatched efficacy data for third-line non-small cell lung cancer (NSCLC) ...
This rare outcome in cartilage repair suggests true biological cartilage regeneration, not merely defect filling Unlike ...
MELBOURNE, Australia and INDIANAPOLIS, Ind., Jan. 20, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: ...
First in class study of an investigational ACTH receptor antagonist aims to address significant unmet need in children and adolescents with classic CAHSAN DIEGO, Jan. 22, 2026(Nasdaq: CRNX) today anno ...
High probability of technical success in pivotal Phase 3 trial based on unmatched efficacy data for third-line non-small cell lung cancer (NSCLC) treatment FDA's Fast Track designation for ateganosine ...
An expert review on refractory constipation established 14 best practice statements addressing key clinical issues for the ...
New blood-based metabolomics test predicts asthma attacks up to five years ahead, helping identify high-risk patients before ...
A new study published in the Journal of American Medical Association showed that veterans, 60 years of age and older who got ...
In an interview with Targeted Oncology, George Mulligan, PhD, discussed the key takeaways from analysis of the Immune Atlas ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results